Shiraz E-Medical Journal

Published by: Kowsar

Serum and 24-Hour Urinary Uric Acid Levels in Patients with Urolithiasis

Mohammad Yazdani 1 , Amid Yazdani 2 , Kourosh Noori-Mahdavi 1 , Mahmoud Kabiri 1 , Shahzad Baradaran 3 and Hamid Nasri 4 , *
Authors Information
1 Department of Urology, Isfahan University of Medical sciences, Isfahan, IR Iran
2 Faculty of Medicine, Isfahan University of Medical sciences, Isfahan, IR Iran
3 Department of Pathology, Jahad Daneshgahi, University of Isfahan, Isfahan, IR Iran
4 Department of Nephrology, Isfahan University of Medical sciences, Isfahan, IR
Article information
  • Shiraz E-Medical Journal: February 01, 2015, 16 (2); e26470
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: December 11, 2014
  • Accepted: December 30, 2014
  • DOI: 10.17795/semj26470

To Cite: Yazdani M, Yazdani A, Noori-Mahdavi K, Kabiri M, Baradaran S, et al. Serum and 24-Hour Urinary Uric Acid Levels in Patients with Urolithiasis, Shiraz E-Med J. 2015 ; 16(2):e26470. doi: 10.17795/semj26470.

Copyright © 2015, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Gyawali PR, Joshi BR, Gurung CK. Correlation of calcium, phosphorus, uric acid and magnesium level in serum and 24 hours urine of patients with urolithiasis. Kathmandu Univ Med J (KUMJ). 2011; 9(34): 54-6[PubMed]
  • 2. Nematbakhsh M, Nasri H. The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study. J Res Med Sci. 2013; 18(7): 626-7[PubMed]
  • 3. Nasri H. Antioxidants for prevention of gentamicin-induced nephrotoxicity. Iran J Kidney Dis. 2014; 8(1): 1-2[PubMed]
  • 4. Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis. 2014; 2(1): 1-3
  • 5. Hajivandi A, Amiri M. World kidney day 2014: Kidney disease and elderly. J Parathyr Dis. 2014; 2(1): 5-6
  • 6. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006; 367(9507): 333-44[DOI][PubMed]
  • 7. Nasri H, Rafieian-Kopaei M. Oxidative stress and aging prevention. Int J Prev Med. 2013; 4(9): 1101-2[PubMed]
  • 8. Pak CY, Resnick MI, Preminger GM. Ethnic and geographic diversity of stone disease. Urology. 1997; 50(4): 504-7[PubMed]
  • 9. Nasri H. Re: effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis. 2013; 7(5): 414-5[PubMed]
  • 10. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathol. 2012; 1(3): 177-82[DOI][PubMed]
  • 11. Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis. 2014; 2(1): 1-2
  • 12. Baradaran A. Primary hyperparathyroidism and kidney; recent findings. J Parathyr Dis. 2014; 2(1): 7-10
  • 13. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15(12): 3225-32[DOI][PubMed]
  • 14. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J nephrol. 1999; 13: 45-50
  • 15. Nasri H. Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients. J Parathyr Dis. 2014; 1(1): 13-6
  • 16. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012; 1(3): 162-3[DOI][PubMed]
  • 17. Nasri H. Comment on: A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats. J Res Med Sci. 2013; 18(12): 1119-20[PubMed]
  • 18. Nasri H. Impact of diabetes mellitus on parathyroid hormone in hemodialysis patients. J Parathyr Dis. 2014; 1(1): 9-11
  • 19. Silva SF, Silva SL, Campos Hde H, Daher Ede F, Silva CA. [Demographic, clinical and laboratory data of patients with urinary lithiasis in Fortaleza, Ceara]. J Bras Nefrol. 2011; 33(3): 295-9[PubMed]
  • 20. Ardalan M-R, Nasri H. Acute kidney injury; the focus of world kidney day in 2013. J Nephropharmacol. 2015; 2(2): 15-6
  • 21. Yamaguchi S. [Relationship between metabolic syndrome and urinary stone disease]. Clin Calcium. 2011; 21(10): 1489-95[PubMed]
  • 22. Nasri H, Rafieian-Kopaei M. Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study. J Nephropharmacol. 2015; 1(2): 15-6
  • 23. Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Ethanolic extract of garlic for attenuation of gentamicin-induced nephrotoxicity in Wistar rats. Iran J Kidney Dis. 2013; 7(5): 376-82[PubMed]
  • 24. Baradaran A, Nasri H, Rafieian-Kopaei M. Comment on: Anti-Oxidative Stress Activity of Stachys lavandulifolia Aqueous Extract in Humans. Cell J. 2013; 15(3): 272-3[PubMed]
  • 25. Nasri H, Rafieian-Kopaei M. Association of serum vitamin D level with age in individuals with normal renal function. J Nephropharmacol. 2015; 1(1): 7-9
  • 26. Kanamaru H, Sasaki M, Ohshiro K, Komatz Y. [A clinical study of urolithiasis in Shizuoka City Hospital--stone analysis and 24-hour urine calcium and uric acid levels]. Hinyokika Kiyo. 1985; 31(6): 915-20[PubMed]
  • 27. Gheissari A, Rezaii Z, Merrikhi A, Madihi Y, Kelishadi R. Association of neutrophil gelatinase associated lipocalin and cystatin-C with kidney function in children with nephrotic syndrome. Int J Prev Med. 2013; 4(8): 956-63[PubMed]
  • 28. Moussavi H-R. Osteoporosis in chronic kidney disease; a mini-review on current knowledge. J Parathyr Dis. 2014; 1(1): 5-8
  • 29. Nasri H. Correlation of serum magnesium with serum levels of 25-hydroxyvitamin D in hemodialysis patients. J Parathyr Dis. 2014; 2(1): 11-3
  • 30. Nasri H, Rafieian-Kopaei M. Parathyroid hormone in renal transplanted recipients; a single center study. J Nephropharmacol. 2015; 2(1): 3-4
  • 31. Freitas Junior CH, Mazzucchi E, Danilovic A, Brito AH, Srougi M. Metabolic assessment of elderly men with urolithiasis. Clinics (Sao Paulo). 2012; 67(5): 457-61[PubMed]
  • 32. Spasovski D. Renal markers for assessment of renal tubular and glomerular dysfunction. J Nephropharmacol. 2015; 2(2): 23-5
  • 33. Tavafi M. Complexity of diabetic nephropathy pathogenesis and design of investigations. J Renal Inj Prev. 2013; 2(2): 59-62[DOI][PubMed]
  • 34. Milosevic D, Batinic D, Konjevoda P, Blau N, Stambuk N, Nizic L, et al. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children. J Chem Inf Comput Sci. 2003; 43(6): 1844-7[DOI][PubMed]
  • 35. Abe T, Akakura K, Kawaguchi M, Ueda T, Ichikawa T, Ito H, et al. Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. J Endourol. 2005; 19(7): 768-73[DOI][PubMed]
  • 36. Albala DM, Assimos DG, Clayman RV, Denstedt JD, Grasso M, Gutierrez-Aceves J, et al. Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J Urol. 2001; 166(6): 2072-80[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments